376 related articles for article (PubMed ID: 25342318)
1. Stem cell treatment for Alzheimer's disease.
Li M; Guo K; Ikehara S
Int J Mol Sci; 2014 Oct; 15(10):19226-38. PubMed ID: 25342318
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease: Mechanism and Approach to Cell Therapy.
Amemori T; Jendelova P; Ruzicka J; Urdzikova LM; Sykova E
Int J Mol Sci; 2015 Nov; 16(11):26417-51. PubMed ID: 26556341
[TBL] [Abstract][Full Text] [Related]
3. Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.
Pacheco-Herrero M; Soto-Rojas LO; Reyes-Sabater H; Garcés-Ramirez L; de la Cruz López F; Villanueva-Fierro I; Luna-Muñoz J
J Alzheimers Dis; 2021; 84(3):917-935. PubMed ID: 34633316
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapy for Alzheimer's disease.
Abdel-Salam OM
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):459-85. PubMed ID: 21495961
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of Human Amniotic Epithelial Stem Cells in a Transgenic Mouse Model of Alzheimer's Disease.
Kim KY; Suh YH; Chang KA
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290355
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy.
Derakhshankhah H; Sajadimajd S; Jafari S; Izadi Z; Sarvari S; Sharifi M; Falahati M; Moakedi F; Muganda WCA; Müller M; Raoufi M; Presley JF
Nanomedicine; 2020 Feb; 24():102149. PubMed ID: 31927133
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
9. Amyloid plaque imaging in vivo: current achievement and future prospects.
Nordberg A
Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S46-50. PubMed ID: 18188557
[TBL] [Abstract][Full Text] [Related]
10. A Unifying Hypothesis for Alzheimer's Disease: From Plaques to Neurodegeneration.
Edwards FA
Trends Neurosci; 2019 May; 42(5):310-322. PubMed ID: 31006494
[TBL] [Abstract][Full Text] [Related]
11. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls.
Bhatti JS; Khullar N; Mishra J; Kaur S; Sehrawat A; Sharma E; Bhatti GK; Selman A; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166712. PubMed ID: 37030521
[TBL] [Abstract][Full Text] [Related]
12. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
Ashrafian H; Zadeh EH; Khan RH
Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
[TBL] [Abstract][Full Text] [Related]
13. On the prevention and treatment of Alzheimer's disease: Control the promoters and look beyond the brain.
Goldstein MR; Cheslock M
Med Hypotheses; 2021 Sep; 154():110645. PubMed ID: 34315048
[TBL] [Abstract][Full Text] [Related]
14. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
Wilcock DM
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
[TBL] [Abstract][Full Text] [Related]
15. Biological Signatures of Alzheimer's Disease.
Sharma P; Sharma A; Fayaz F; Wakode S; Pottoo FH
Curr Top Med Chem; 2020; 20(9):770-781. PubMed ID: 32108008
[TBL] [Abstract][Full Text] [Related]
16. The hippocampus in neurodegenerative disease.
Moodley KK; Chan D
Front Neurol Neurosci; 2014; 34():95-108. PubMed ID: 24777134
[TBL] [Abstract][Full Text] [Related]
17. TREM2 Function in Alzheimer's Disease and Neurodegeneration.
Ulrich JD; Holtzman DM
ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967
[TBL] [Abstract][Full Text] [Related]
18. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
19. The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence.
Assefa BT; Tafere GG; Wondafrash DZ; Gidey MT
Biomed Res Int; 2020; 2020():9895121. PubMed ID: 32149150
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease.
Roy J; Tsui KC; Ng J; Fung ML; Lim LW
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
